Cellect Biotechnology Ltd is a biotechnology business based in the US. Cellect Biotechnology shares (APOP) are listed on the NASDAQ and all prices are listed in US Dollars. Cellect Biotechnology employs 12 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Cellect Biotechnology
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – APOP – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Cellect Biotechnology stock price (NASDAQ: APOP)Use our graph to track the performance of APOP stocks over time.
Cellect Biotechnology shares at a glance
|Latest market close||$3.13|
|52-week range||$1.65 - $4.42|
|50-day moving average||$3.54|
|200-day moving average||$3.16|
|Wall St. target price||$12.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.85|
Buy Cellect Biotechnology shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Cellect Biotechnology stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cellect Biotechnology price performance over time
|1 week (2021-07-13)||N/A|
|1 month (2021-06-24)||-13.77%|
|3 months (2021-04-20)||N/A|
|6 months (2021-01-20)||N/A|
|1 year (2020-07-20)||N/A|
|2 years (2019-07-20)||N/A|
|3 years (2018-07-20)||N/A|
|5 years (2016-07-20)||N/A|
Cellect Biotechnology financials
|Gross profit TTM||$0|
|Return on assets TTM||-42.77%|
|Return on equity TTM||-121.25%|
|Market capitalisation||$15.8 million|
TTM: trailing 12 months
Shorting Cellect Biotechnology shares
There are currently 170,695 Cellect Biotechnology shares held short by investors – that's known as Cellect Biotechnology's "short interest". This figure is 1011.2% up from 15,362 last month.
There are a few different ways that this level of interest in shorting Cellect Biotechnology shares can be evaluated.
Cellect Biotechnology's "short interest ratio" (SIR)
Cellect Biotechnology's "short interest ratio" (SIR) is the quantity of Cellect Biotechnology shares currently shorted divided by the average quantity of Cellect Biotechnology shares traded daily (recently around 4.3 million). Cellect Biotechnology's SIR currently stands at 0.04. In other words for every 100,000 Cellect Biotechnology shares traded daily on the market, roughly 40 shares are currently held short.
However Cellect Biotechnology's short interest can also be evaluated against the total number of Cellect Biotechnology shares, or, against the total number of tradable Cellect Biotechnology shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cellect Biotechnology's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Cellect Biotechnology shares in existence, roughly 40 shares are currently held short) or 0.0478% of the tradable shares (for every 100,000 tradable Cellect Biotechnology shares, roughly 48 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Cellect Biotechnology.
Find out more about how you can short Cellect Biotechnology stock.
Cellect Biotechnology share dividends
We're not expecting Cellect Biotechnology to pay a dividend over the next 12 months.
Have Cellect Biotechnology's shares ever split?
Cellect Biotechnology's shares were split on a 1:5 basis on 22 October 2019. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cellect Biotechnology shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Cellect Biotechnology shares which in turn could have impacted Cellect Biotechnology's share price.
Cellect Biotechnology share price volatility
Over the last 12 months, Cellect Biotechnology's shares have ranged in value from as little as $1.65 up to $4.42. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cellect Biotechnology's is 1.829. This would suggest that Cellect Biotechnology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Cellect Biotechnology overview
Cellect Biotechnology Ltd. , a biotechnology company, engages in developing ApoGraft, a technology platform that functionally selects stem cells to enhance the safety of regenerative medicine and stem cell therapies in Israel. The company develops ApoTainer, a kit for hematopoietic stem cell transplantation procedures. It has collaborations with the denovoMATRIX group of the Technische Universität Dresden to conduct examinations into the tentative synergy between ApoGraft and denovoMAtrix technology for the purpose of evaluating collaborative development of products for regenerative medicine; Cell2in Inc. to conduct scientific evaluations combining ApoGraft with Cell2in's identification technology FreSHtracer, which monitors stem cell quality by utilizing a fluorescent dye to characterize their oxidative stress state; and XNK therapeutics to focus on the development of cell-based therapeutics from NK cells. The company was formerly known as Cellect Biomed Ltd. and changed its name to Cellect Biotechnology Ltd.
Cellect Biotechnology in the news
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Midday Meme Stock Report for 7/1: Cellect Biotech, ContextLogic, Workhorse, Senseonics
Short Squeeze Stocks: CLOV, AEI and 3 Other Stocks Experts Think Are Ready to Pop
Frequently asked questionsWhat percentage of Cellect Biotechnology is owned by insiders or institutions?
Currently 8.031% of Cellect Biotechnology shares are held by insiders and 16.578% by institutions. How many people work for Cellect Biotechnology?
Latest data suggests 12 work at Cellect Biotechnology. When does the fiscal year end for Cellect Biotechnology?
Cellect Biotechnology's fiscal year ends in December. Where is Cellect Biotechnology based?
Cellect Biotechnology's address is: 23 Hata?as Street, Kfar Saba, Israel, 44425 What is Cellect Biotechnology's ISIN number?
Cellect Biotechnology's international securities identification number is: US15116C2017 What is Cellect Biotechnology's CUSIP number?
Cellect Biotechnology's Committee on Uniform Securities Identification Procedures number is: 000241018
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert